Advertising


ARCHIVESLATEST ISSUE
ONLINEARTICLES
IN PRESSTHEMATIC
ISSUES


Free articles Free articles

Iconography

Online Complements

Journal of the American Academy of Dermatology


Vol 68 - Numéro 4 Supplément 1
Poster Abstracts
P. A1-A5
© 2019, Elsevier Masson SAS

Print

@@113004a@@ 5 @@113004b@@ 10
1234[5]678910
Genodermatoses
Genodermatoses
Survival with 2 DNA repair disorders
page AB100

Genodermatoses
Trichorhinophalangeal syndrome type I: Clinical and molecular features of a sporadic Asian patient
page AB100

Hair and Nail Disorders
Hair and Nail Disorders
A comparison among commonly used nail products on nail mechanical properties
page AB101

Hair and Nail Disorders
A nodule in the toe: Case report of eccrine poroma
page AB101

Hair and Nail Disorders
A phase II study of efinaconazole solution for the once-daily treatment of toenail onychomycosis: Primary efficacy assessment
page AB101

Hair and Nail Disorders
A phase II study of efinaconazole solution for the once-daily treatment of toenail onychomycosis: Secondary efficacy assessment
page AB102

Hair and Nail Disorders
Alarming trends toward clinical diagnosis and management of psoriatic nails in the general practitioners and nondermatologist specialists
page AB102

Hair and Nail Disorders
An innovative terbinafine transungual solution (P-3058): Dose finding investigation on clinical benefit in patients affected by mild-to-moderate toe onychomycosis
page AB102

Hair and Nail Disorders
Association between epidermal growth factor and epidermal growth factor receptor gene polymorphisms and susceptibility to alopecia areata in Korean population
page AB103

Hair and Nail Disorders
Autologous platelet-rich plasma as a potential therapeutic tool in androgenetic alopecia
page AB103

Hair and Nail Disorders
Becker nevus of the face with asymmetrical growth of beard hair
page AB103

Hair and Nail Disorders
Cross-section trichometry, a clinical tool for assessing the progression and treatment response of alopecia
page AB103

Hair and Nail Disorders
Development of an optimal formulation for efinaconazole a novel antifungal agent for the treatment of onychomycosis by topical application
page AB104

Hair and Nail Disorders
Dissecting folliculitis
page AB104

Hair and Nail Disorders
Effect of an innovative terbinafine nail solution (P-3058) on in vitro nail experimental infections
page AB104

Hair and Nail Disorders
Efinaconazole 10% solution a new triazole antifungal developed for topical onychomycosis treatment: Nail penetration and systemic absorption
page AB104

Hair and Nail Disorders
Efinaconazole 10% solution: Nonclinical safety supports topical use in onychomycosis
page AB105

Hair and Nail Disorders
Evaluation of safety profile, pharmacokinetics, and clinical benefit of an innovative terbinafine transungual solution (P-3058): A phase I study in patients with mild-to-moderate distal subungual onychomycosis
page AB105

Hair and Nail Disorders
Facial lichen planopilaris: An atypical presentation and review of a new variant
page AB105

Hair and Nail Disorders
Follicular red dots in areas with an anatomic colocalization of alopecia areata and vitiligo
page AB105

Hair and Nail Disorders
Hereditary leukonychia and koilonychia without associated findings
page AB106

Hair and Nail Disorders
In vitro antifungal activity of efinaconazole, a novel triazole antifungal, against a variety of pathogenic fungi
page AB106

Hair and Nail Disorders
In vitro evaluation of the potential of ciclopirox to induce resistance in Trichophyton rubrum, in comparison to terbinafine, amorolfine, and itraconazole
page AB106

Hair and Nail Disorders
Incidence of alopecia areata in Olmsted County, Minnesota 1990-2009
page AB106

Hair and Nail Disorders
Incidence of alopecia from endocrine therapies in cancer
page AB107

Hair and Nail Disorders
Insulin resistance and hair disorders, idiopathic hirsutism, and androgenic alopecia
page AB107

Hair and Nail Disorders
Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
page AB107

Hair and Nail Disorders
Onychomatricoma with classic features: Case report and review of the literature
page AB107

Hair and Nail Disorders
Premature graying of scalp hairs treated with ferrous sulfate
page AB108

Hair and Nail Disorders
Prevalance, clinical features and evaluation of the risk factors for onychocriptosis in adult diabetic patients in outpatient clinic
page AB108

Hair and Nail Disorders
Single and repeated dose of finasteride topical solution in subjects with androgenetic alopecia: A pharmacokinetic and pharmacodynamic study
page AB108

Hair and Nail Disorders
Sparse hair in a female toddler
page AB108

Hair and Nail Disorders
Subungual spindle cell lipoma: Case report
page AB109

Hair and Nail Disorders
Subungueal melanoma in a young patient: Case report
page AB109

Hair and Nail Disorders
Terbinafine nail solutions for topical treatment of onychomycosis: Ex vivo study on penetration/retention through and into keratin membranes
page AB109

Hair and Nail Disorders
The effect of a novel zinc pyrithione hair care system on female scalp condition
page AB109

Hair and Nail Disorders
Toenail onychomatricoma: A differential diagnosis of melanonychia
page AB110

Hair and Nail Disorders
Uncombable hair syndrome: A case presentation
page AB110

Hair and Nail Disorders
Unique properties of efinaconazole 10% solution, a new topical treatment for onychomycosis
page AB110

Immunodermatology and Blistering Disorders
Immunodermatology and Blistering Disorders
A case of epidermolysis bullosa acquisita treated with rituxmab with comparisons to other epidermolysis bullosa acquisita reports and pemphiguis
page AB110

Immunodermatology and Blistering Disorders
A distinct oral phenotype in immunoglobulin A predominant mucous membrane pemphigoid
page AB111

Immunodermatology and Blistering Disorders
A successful single-cycle rituximab treatment in radiation-induced pemphigus vulgaris with squamous cell carcinoma of the tongue and immunoglobulin G antibodies to desmocollins
page AB111

Immunodermatology and Blistering Disorders
An erythema multiforme–like presentation of Sweet syndrome
page AB111

Immunodermatology and Blistering Disorders
Bullous pemphigoid and dermatitis herpetiformis overlap
page AB111

Immunodermatology and Blistering Disorders
Case of subepidermal blistering disease in a 14-month-old infant
page AB112

Immunodermatology and Blistering Disorders
Drug-induced linear immunoglobulin A bullous dermatosis (drug associated) Vancomycin
page AB112

Immunodermatology and Blistering Disorders
Efficacy and safety of rituximab treatment in Indian pemphigus patients
page AB112

Immunodermatology and Blistering Disorders
Eosinophilic folliculitis successfully treated with intravenous immunoglobulin: Case report
page AB112

Immunodermatology and Blistering Disorders
Epitope spreading in pemphigus patients from São Paulo, Brazil: A 10-year follow-up
page AB113

Immunodermatology and Blistering Disorders
Erythema multiforme associated with the combined use of lamotrigine and cyclobenzaprine: A case report
page AB113

Immunodermatology and Blistering Disorders
Intravenous immunoglobulin for the treatment of quetiapin-induced bullous pemphigoid in an HIV-infected patient
page AB113

Immunodermatology and Blistering Disorders
Linear IgA bullous dermatosis herpeticum: Disseminated herpes simplex virus infection within the lesions of vancomycin-induced linear IgA bullous dermatosis
page AB113

Immunodermatology and Blistering Disorders
Ofloxacin-induced linear IgA dermatosis mimicking toxic epidermal necrolysis
page AB114

Immunodermatology and Blistering Disorders
Paraneoplastic pemphigus in an HIV-positive patient: First reported case
page AB114

Immunodermatology and Blistering Disorders
Paraneoplastic pemphigus: A case report
page AB114

Immunodermatology and Blistering Disorders
Pemphigoid gestationis: Debut in the third preganancy
page AB114

Immunodermatology and Blistering Disorders
Propylthiouracil-induced antineutrophil cytoplasmic antibody (anti-MPO and anti-PR3) positive leukocytoclastic vasculitis in a patient with Graves disease presenting as purpura fulminans
page AB115

Immunodermatology and Blistering Disorders
The emerging phenotype of ovarian driven autoimmunity: Annular, lateralizing, and microvesicular skin diseases in women
page AB115

Immunodermatology and Blistering Disorders
The value of trichoscopy in differential diagnosis of isolated scalp lesions in pemphigus
page AB115

Immunodermatology and Blistering Disorders
Treatment of coexisting pemphigus foliaceus and psoriasis with adalimumab
page AB115

Infection—Bacterial and Parasitic
Infection—Bacterial and Parasitic
Acute ulcerative lesions in HIV seropositive patient
page AB116

Infection—Bacterial and Parasitic
Clinical exuberance of Hansen disease: Case report
page AB116

Infection—Bacterial and Parasitic
Clinical management with endovenous corticotherapy in patients with leprosy reactions
page AB116

Infection—Bacterial and Parasitic
Cutaneous larva migrans: An imported case
page AB116

Infection—Bacterial and Parasitic
Demodicosis: Clinical, dermatoscopic, and microscopic correlation
page AB117

Infection—Bacterial and Parasitic
Diagnosis of late multibacillary leprosy endemic country: Keeping still endemic?
page AB117

Infection—Bacterial and Parasitic
Difficulty in diagnosing childhood leprosy
page AB117

Infection—Bacterial and Parasitic
Disseminated Mycobacterium chelonae infection in a patient with relapsing polychondritis
page AB117

Infection—Bacterial and Parasitic
Erysipelas-like cutaneous leishmaniasis in a white man
page AB118

Infection—Bacterial and Parasitic
Erythema induratum of Bazin secondary to tuberculin skin test
page AB118

Infection—Bacterial and Parasitic
Evaluation of 166 leprosy patients under 15 years of age in a public hospital, Rio de Janeiro/Brazil
page AB118

Infection—Bacterial and Parasitic
Generalized granuloma annulare in patients with syphilis
page AB118

Infection—Bacterial and Parasitic
Greater psychiatric morbidity in patients with bacterial infections of the skin versus cutaneous neoplasms: Analysis of an epidemiologic sample of 74,753 patient visits for dermatologic disorders
page AB119

Infection—Bacterial and Parasitic
Hansen disease after etanercept treatment
page AB119

Infection—Bacterial and Parasitic
How scabies crusts: Dermatoscopy aspects of Norwegian scabies
page AB119

Infection—Bacterial and Parasitic
Late reversal reaction 6 months after completion of WHO standard treatment for multibacillary leprosy
page AB119

Infection—Bacterial and Parasitic
Leprosy: Care for the prevention of plantar ulcer
page AB120

Infection—Bacterial and Parasitic
Leprosy in children: A warning to endemic countries
page AB120

Infection—Bacterial and Parasitic
Leprosy: Importance of differential diagnoses in an endemic area
page AB120

Infection—Bacterial and Parasitic
Leprosy: The importance of investigating household contacts: A case report
page AB120

Infection—Bacterial and Parasitic
Mites and burrows are frequently found in nodular scabies by dermatoscopy and histopathology
page AB121

Infection—Bacterial and Parasitic
Mycetoma: A therapeutic challenge
page AB121

Infection—Bacterial and Parasitic
Mycobacteria mucogenicum infection following a cosmetic procedure with poly-L-lactic acid
page AB121

Infection—Bacterial and Parasitic
Mycobacterium abscessus infection occurring within lesions of gouty tophi
page AB121

Infection—Bacterial and Parasitic
Necrobiontophage myiasis
page AB122

Infection—Bacterial and Parasitic
Neuropathy in patients with leprosy and diabetes: The importance of clinical signs
page AB122

Infection—Bacterial and Parasitic
Nodular leprosy in children
page AB122

Infection—Bacterial and Parasitic
Oral lesions as the only manifestation of secondary syphilis
page AB122

Infection—Bacterial and Parasitic
Outbreak of Panton–Valentine leukocidin–positive Staphylococcus aureus in dermatology inpatients in the UK: An escalating phenomenon?
page AB123

Infection—Bacterial and Parasitic
Oxidative stress in type I lepra reaction and the effect of treatment
page AB123

Infection—Bacterial and Parasitic
Papulonecrotic tuberculid revealing ganglionar tuberculosis
page AB123

Infection—Bacterial and Parasitic
Scrofuloderma: A case report
page AB123

Infection—Bacterial and Parasitic
Secondary syphilis with exuberant manifestations
page AB124

Infection—Bacterial and Parasitic
Simultaneous primary and secondary syphilis in an HIV-positive patient
page AB124

Infection—Bacterial and Parasitic
Tattoo inoculation leprosy in a patient treated for pulmonary tuberculosis
page AB124

Infection—Bacterial and Parasitic
The Edinburgh experience of cutaneous Mycobacterium chelonae infection
page AB124

Infection—Bacterial and Parasitic
The perils of breast plastic surgery
page AB125

Infection—Bacterial and Parasitic
Therapeutic approach of leprosy in pregnancy
page AB125

Infection—Bacterial and Parasitic
Unusual presentation of syphilis in HIV patients
page AB125

Infection—Fungal
Infection—Fungal
An unusual epidemic of sporotrichosis in Rio de Janeiro
page AB125

@@113004a@@ 5 @@113004b@@ 10
1234[5]678910
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.